ISPE Elects Thomas B. Hartman as New CEO and President

Tom Hartman will act as the International Society for Pharmaceutical...
Tom Hartman will act as the International Society for Pharmaceutical Engineering (ISPE)’s new permanent CEO and President, effective 1 June 2020. © ISPE

The International Society for Pharmaceutical Engineering (ISPE) has appointed Thomas (Tom) B. Hartman as the organization’s new permanent CEO and President, effective 1 June 2020. He will succeed Tim Howard, who served as the organization’s acting CEO and president after John Bournas, the former CEO and president, stepped down from his position effective Jan. 8, 2020.

Hartman has a history of success in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, for GlaxoSmithKline (GSK). His extensive executive leadership experience and strong commitment to product quality, includes all aspects of biopharmaceutical CMC supply chain management. Most recently his team established manufacturing capability for the supply of viral vectors, enabling GSK’s cell and gene therapy platform. 

“The recent pandemic highlights the need for effective platforms for collaboration to resolve complex industry challenges,” said Hartman. “ISPE and its more than 18,000 Members are positioned well to support the entire pharmaceutical industry in the development and manufacturing of transformational medicines for patients. It is a true privilege to be given the opportunity to play a significant role in the industry, and I look forward to working with the ISPE Board, staff, worldwide Membership, and all industry stakeholders to further advance and build on ISPE's success over the past 40 years.”

Hartman, who holds a degree in Mechanical Engineering from Villanova University and an MBA from Eastern University, is experienced in all aspects of biopharmaceutical CMC functions including cell banking, materials management, manufacturing including microbial and mammalian expression systems, and support functions including facility monitoring, engineering, capital project management, validation, and quality control, often leading negotiations with international external supply CMO/CRO’s. 

Prior to joining GSK in 2001, he held multiple engineering and operations roles with a major US-based chemical manufacturer, including a five-year expatriate role in the Netherlands and the UK, culminating with responsibilities as head of engineering at a large chemical facility. In his career, Tom has successfully conducted business in multiple countries including the US, UK, East/West Europe, China, Korea, Singapore, India, and Mexico.  

Hartman has been a Member of ISPE since 2001 and was elected to the ISPE Board of Directors in 2013, most recently serving as the 2019–2020 Vice Chair.

Company

ISPE D/A/CH e.V.

Europastrasse 18
8152 Glattbrugg/Zürich
Switzerland

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.